For the p53 wild type breast cancer cell line MCF-7, a total of 27 combinations (29.7%) were identified, including 16 “possible” (17.6%), ten “likely” (11.0%) and one “very likely” (1.1%) synergism. The gene discussed is TP53; the disease is breast cancer.